Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2022-03-25 Purchase | 2022-03-28 8:00 pm | Oncocyte Corp | OCX | Ross Douglas T. Chief Scientific Officer | 15,000 | $1.4 | $21,000 | 20,317 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2022-12-21 Option Award | 2022-12-22 6:57 pm | N/A N/A | Oncocyte Corp | OCX | Ross Douglas T. Former CSO | 213,797 | $0 | 234,114 (Direct) | View |
2022-12-16 Disposition | 2022-12-20 4:05 pm | N/A N/A | Oncocyte Corp | OCX | Ross Douglas T. Former CSO. | 576,772 | $0 | 298,545 (Direct) | View |
2022-08-15 Option Award | 2022-08-17 8:24 pm | N/A N/A | Oncocyte Corp | OCX | Ross Douglas T. Chief Scientific Officer | 150,000 | $0 | 170,317 (Direct) | View |
2022-03-15 Option Award | 2022-03-17 9:29 pm | N/A 2032-03-15 | Oncocyte Corp | OCX | Ross Douglas T. Chief Scientific Officer | 200,000 | $0 | 200,000 (Direct) | View |
2021-02-25 Option Award | 2021-03-01 4:23 pm | N/A 2031-02-24 | OncoCyte Corp | OCX | Ross Douglas T. Chief Medical Officer | 255,000 | $5.34 | 255,000 (Direct) | View |
2020-12-11 Option Award | 2020-12-15 06:22 am | N/A N/A | OncoCyte Corp | OCX | Ross Douglas T. CMO | 5,317 | $0 | 5,317 (Direct) | View |
Ownership | 2020-04-02 8:10 pm | N/A 2030-03-22 | OncoCyte Corp | OCX | Ross Douglas T. Chief Medical Officer | 0 | $0 | 250,000 (Direct) | View |